SA
CORT icon

Sanctuary Advisors’s Corcept Therapeutics CORT Stock Holding History

Sanctuary Advisors’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$808K Buy
9,289
+1,582
+21% +$95.5K ﹤0.01% 1611
2026
Q1 		$311K Buy
7,707
+947
+14% +$35.4K ﹤0.01% 2074
2025
Q4 		$235K Sell
6,760
-1,152
-15% -$90.5K ﹤0.01% 2180
2025
Q3 		$658K Sell
7,912
-1,384
-15% -$100K ﹤0.01% 1531
2025
Q2 		$682K Sell
9,296
-1,036
-10% -$75.1K ﹤0.01% 1430
2025
Q1 		$1.18M Sell
10,332
-18,926
-65% -$1.15M 0.01% 1055
2024
Q4 		$2.05M Buy
29,258
+905
+3% +$47.4K 0.01% 848
2024
Q3 		$1.63M Sell
28,353
-2,113
-7% -$75.1K 0.01% 990
2024
Q2 		$695K Buy
+30,466
New +$835K 0.01% 1408

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanctuary Advisors's CORT Position: Q2 2026 in Review

Sanctuary Advisors increased its Corcept Therapeutics (CORT) stake by 21% in Q2 2026, buying an estimated $95.5K and bringing the position to 9,289 shares worth $808K. The position accounts for ﹤0.01% of the portfolio, ranked #1611.

Sanctuary Advisors first reported a position in CORT in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.05M in Q4 2024. 422 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Sanctuary Advisors held 9,289 shares of Corcept Therapeutics worth $808K as of Q2 2026.
  • Sanctuary Advisors bought 1,582 Corcept Therapeutics shares in Q2 2026, an estimated $95.5K.
  • Corcept Therapeutics made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1611 holding.
  • Sanctuary Advisors first reported a position in Corcept Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's Corcept Therapeutics position peaked at $2.05M in Q4 2024.
  • 422 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.